Athens, Greece (OTE) – After 16 years with FAMAR, including the last
4 years as CEO,
Konstantinos Rengis decided to step down from his role for personal
reasons, effective September 29, 2025.
Kostas is widely recognized for his customer-centric approach,
deep knowledge of our industry, and his solution-oriented mindset.
During his tenure, he played a pivotal role in successfully guiding
the company through multiple ownership transitions, improving
operations and customer service and setting a vision for future
growth.
At the same time, FAMAR Group is pleased to announce the
appointment of Dr. Riku Rautsola as CEO, effective September 29,
2025. Riku has served as a non-executive member of FAMAR’s Board of
Directors and an advisor to MidEuropa during the acquisition of FAMAR
last year. Riku is a globally experienced leader in the
pharmaceutical, biotech and CDMO industries, having held CEO and
senior executive positions at several leading companies, creating
sustained profitable growth
Under Riku’s leadership, FAMAR remains committed to serve its
global customers, expand production capacity, accelerate its
development partnerships, and invest in its people. Riku will also
continue to serve as a member of the Board of Directors.
Kostas will support Riku and the Board of Directors in a senior
advisory capacity, focusing on strategic customer relationships and
customer engagement.
„We thank Kostas Rengis for his many years of dedicated service,
and we extend a warm welcome to Riku Rautsola as he leads FAMAR in
this next chapter of growth and transformation“, stated Matthew
Strassberg, Partner and Head of Healthcare at MidEuropa.
About Famar Group
FAMAR is a leading European provider of pharmaceutical and
cosmetic manufacturing and development services. With a legacy of 75
years, FAMAR delivers high-quality dosage forms, including sterile
liquids, solids, and semi-solids, creating value for its clients.
Operating in Spain, Italy, and Greece, employing over 1.850 people
across a network of six production facilities and two R&D centres,
FAMAR supplies a wide range of more than 1.700 different products for
over 80 international markets.
View original content: https://www.prnewswire.co.uk/news-
releases/famar-group-dr-riku-rautsola-appointed-new-ceo-
302569813.html
Digital press kit: http://www.ots.at/pressemappe/PR181083/aom